4//SEC Filing
Gibbs Michael Terrence 4
Accession 0000899243-22-012515
CIK 0001492674other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 6:42 PM ET
Size
8.7 KB
Accession
0000899243-22-012515
Insider Transaction Report
Form 4
Gibbs Michael Terrence
General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-03-24−16,666→ 16,667 total→ Common Stock (16,666 underlying) - Exercise/Conversion
Common Stock
2022-03-24+16,666→ 165,441 total - Tax Payment
Common Stock
2022-03-24$0.44/sh−8,790$3,876→ 156,651 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]8,790 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On March 24, 2020 the reporting person was granted 50,000 RSU's that vest in three equal annual installments commencing on March 24, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001665000
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 6:42 PM ET
- Size
- 8.7 KB